38. Recurrent pediatric brain tumors: The role of surgery

S. Pezzotta, L. Santi, G. Bellantoni, L. Magrassi, M. Arico, D. Locatelli

Research output: Contribution to journalArticle

Abstract

The role of radical surgery and adjuvant therapies in the treatment of new diagnosed brain lesions has been focused in several clinical trials. On the contrary little has been done on recurrent pediatric brain tumors. Aggressive chemotherapy is the standard treatment for brain tumors relapses. The aim of our study is testing a protocol including a reoperation as soon as possible radical. Eligibility criteria were: patients with proved relapse, previously treated, located in a surgically amenable area; life expentancy higher than 2 mos; Karnofsky: 50 or higher; no evidence of extraneural dissemination. Patients with neurofibromatosis are excluded. This study showed that: surgical mortality and morbidity are not increased, never additional difficulties are encountered during reoperation in comparison with surgery of new diagnosed tumors. At present it is impossible to affirm if the aggressive surgical treatment of the relapses is the treatment of choice in all brain tumor recurrences. However our experience in MDB, compared with standard treatment of relapses, is encouraging. Results of surgery are not worse than conservative treatment; also morbidity is similar in two different treatment modalities. The treatment of relapsing pediatric brain tumors still represents a major challenge for neurosurgeon and oncologist. This protocol could be useful for prospective randomized studies trying to solve in a more objetive way the positive role of reoperation in the management of different CNS tumors, particularly in malignant oncotypes.

Original languageEnglish
Pages (from-to)251-252
Number of pages2
JournalItalian Journal of Neurological Sciences
Volume18
Issue number4
Publication statusPublished - 1997

Fingerprint

Brain Neoplasms
Pediatrics
Recurrence
Reoperation
Therapeutics
Morbidity
Neurofibromatoses
Neoplasms
Clinical Trials
Prospective Studies
Drug Therapy
Mortality
Brain

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Neurology

Cite this

38. Recurrent pediatric brain tumors : The role of surgery. / Pezzotta, S.; Santi, L.; Bellantoni, G.; Magrassi, L.; Arico, M.; Locatelli, D.

In: Italian Journal of Neurological Sciences, Vol. 18, No. 4, 1997, p. 251-252.

Research output: Contribution to journalArticle

Pezzotta, S, Santi, L, Bellantoni, G, Magrassi, L, Arico, M & Locatelli, D 1997, '38. Recurrent pediatric brain tumors: The role of surgery', Italian Journal of Neurological Sciences, vol. 18, no. 4, pp. 251-252.
Pezzotta, S. ; Santi, L. ; Bellantoni, G. ; Magrassi, L. ; Arico, M. ; Locatelli, D. / 38. Recurrent pediatric brain tumors : The role of surgery. In: Italian Journal of Neurological Sciences. 1997 ; Vol. 18, No. 4. pp. 251-252.
@article{632166a9f58a46fe9e81a20961e3961c,
title = "38. Recurrent pediatric brain tumors: The role of surgery",
abstract = "The role of radical surgery and adjuvant therapies in the treatment of new diagnosed brain lesions has been focused in several clinical trials. On the contrary little has been done on recurrent pediatric brain tumors. Aggressive chemotherapy is the standard treatment for brain tumors relapses. The aim of our study is testing a protocol including a reoperation as soon as possible radical. Eligibility criteria were: patients with proved relapse, previously treated, located in a surgically amenable area; life expentancy higher than 2 mos; Karnofsky: 50 or higher; no evidence of extraneural dissemination. Patients with neurofibromatosis are excluded. This study showed that: surgical mortality and morbidity are not increased, never additional difficulties are encountered during reoperation in comparison with surgery of new diagnosed tumors. At present it is impossible to affirm if the aggressive surgical treatment of the relapses is the treatment of choice in all brain tumor recurrences. However our experience in MDB, compared with standard treatment of relapses, is encouraging. Results of surgery are not worse than conservative treatment; also morbidity is similar in two different treatment modalities. The treatment of relapsing pediatric brain tumors still represents a major challenge for neurosurgeon and oncologist. This protocol could be useful for prospective randomized studies trying to solve in a more objetive way the positive role of reoperation in the management of different CNS tumors, particularly in malignant oncotypes.",
author = "S. Pezzotta and L. Santi and G. Bellantoni and L. Magrassi and M. Arico and D. Locatelli",
year = "1997",
language = "English",
volume = "18",
pages = "251--252",
journal = "Italian Journal of Neurological Sciences",
issn = "0392-0461",
publisher = "Springer Verlag",
number = "4",

}

TY - JOUR

T1 - 38. Recurrent pediatric brain tumors

T2 - The role of surgery

AU - Pezzotta, S.

AU - Santi, L.

AU - Bellantoni, G.

AU - Magrassi, L.

AU - Arico, M.

AU - Locatelli, D.

PY - 1997

Y1 - 1997

N2 - The role of radical surgery and adjuvant therapies in the treatment of new diagnosed brain lesions has been focused in several clinical trials. On the contrary little has been done on recurrent pediatric brain tumors. Aggressive chemotherapy is the standard treatment for brain tumors relapses. The aim of our study is testing a protocol including a reoperation as soon as possible radical. Eligibility criteria were: patients with proved relapse, previously treated, located in a surgically amenable area; life expentancy higher than 2 mos; Karnofsky: 50 or higher; no evidence of extraneural dissemination. Patients with neurofibromatosis are excluded. This study showed that: surgical mortality and morbidity are not increased, never additional difficulties are encountered during reoperation in comparison with surgery of new diagnosed tumors. At present it is impossible to affirm if the aggressive surgical treatment of the relapses is the treatment of choice in all brain tumor recurrences. However our experience in MDB, compared with standard treatment of relapses, is encouraging. Results of surgery are not worse than conservative treatment; also morbidity is similar in two different treatment modalities. The treatment of relapsing pediatric brain tumors still represents a major challenge for neurosurgeon and oncologist. This protocol could be useful for prospective randomized studies trying to solve in a more objetive way the positive role of reoperation in the management of different CNS tumors, particularly in malignant oncotypes.

AB - The role of radical surgery and adjuvant therapies in the treatment of new diagnosed brain lesions has been focused in several clinical trials. On the contrary little has been done on recurrent pediatric brain tumors. Aggressive chemotherapy is the standard treatment for brain tumors relapses. The aim of our study is testing a protocol including a reoperation as soon as possible radical. Eligibility criteria were: patients with proved relapse, previously treated, located in a surgically amenable area; life expentancy higher than 2 mos; Karnofsky: 50 or higher; no evidence of extraneural dissemination. Patients with neurofibromatosis are excluded. This study showed that: surgical mortality and morbidity are not increased, never additional difficulties are encountered during reoperation in comparison with surgery of new diagnosed tumors. At present it is impossible to affirm if the aggressive surgical treatment of the relapses is the treatment of choice in all brain tumor recurrences. However our experience in MDB, compared with standard treatment of relapses, is encouraging. Results of surgery are not worse than conservative treatment; also morbidity is similar in two different treatment modalities. The treatment of relapsing pediatric brain tumors still represents a major challenge for neurosurgeon and oncologist. This protocol could be useful for prospective randomized studies trying to solve in a more objetive way the positive role of reoperation in the management of different CNS tumors, particularly in malignant oncotypes.

UR - http://www.scopus.com/inward/record.url?scp=33746371417&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746371417&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33746371417

VL - 18

SP - 251

EP - 252

JO - Italian Journal of Neurological Sciences

JF - Italian Journal of Neurological Sciences

SN - 0392-0461

IS - 4

ER -